What Do People Think About When Choosing Health Insurance Plans?
Here is a discussion I had with Tess Vigeland of Los Angeles Public Radio about the psychology of choosing health plans.
(Click here to view comments)
Similar Posts
Is the American Healthcare System Addicted to Expensive Drugs?
ByadminTo almost every claim that the American healthcare system is overpriced, defenders of the United States can point to the comparison problem—it is not fair to compare American surgeons, or hospitals, to our peers in Europe when American surgeons and hospitals are not the same as in those other countries. Our surgeons are better trained,…
Health Insurance Trends in One Picture
ByadminHere is data from the CDC, on the percent of Americans without health insurance. It shows that Obamacare, for all its strengths and weaknesses, is definitely addressing one major problem in the US:
Will A "Red Light" Be An Effective Nudge To Stop People From Drinking Coke?
ByadminSo many foods beckoning us from the grocery store shelves – but which ones are healthy for us to consume? We could study Nutritional Facts labels, but that feels as challenging as the math portion of the SAT, with so much numerical information to process. The label tells us how many calories are in the…
What Does Health Insurance Consolidation Mean for You?
ByadminListen to this Marketplace report on consolidation in the world of health insurance. It is an interesting report, and also the first public acknowledgment that I am, gulp, a Business Professor!
The True Cost Of Low Drug Prices
ByadminIndia is not, yet, a wealthy country. Nevertheless its people experience many of the same expensive-to-treat illnesses as wealthier populations in the U.S. and Europe. Therefore the country has made a series of policy decisions designed to lower the cost of medical treatments. For example, until 2005, it offered no – I repeat, no –…
Bad News for Pharmaceutical Companies about Spending Trends
ByadminFor years now, the pharmaceutical industry has justified its prices and its profits by reminding us that their products eventually go off patent, and are then offered cheaply to people around the world in generic form. They warned us that the pipeline for new and innovative drugs is less and less promising, because so many…